GL1X · GenesisL1 explorer

Research workbench

2BDJ: Src kinase in complex with inhibitor AP23464

Analyse 2BDJ: Src kinase in complex with inhibitor AP23464 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2BDJ
Type
protein
Length
254 residues
Chains
1
Method
x-ray diffraction
Deposited
20-OCT-05
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proto-oncogene tyrosine-protein kinase src
EC
2.7.1.112
UniProt
P12931
Ligands
HET
Pockets
1 · best druggability 0.68

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProto-oncogene tyrosine-protein kinase src (EC 2.7.1.112)protein25441% helix, 18% strandP12931

Ligands and binding sites

  • HET · 3-[2-(2-cyclopentyl-6-{[4-(dimethylphosphoryl)phenyl]amino}-9H-purin-9-yl)ethyl]phenol · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13940.680.8040HET

Compared structures

  • 2BDJ · Src kinase in complex with inhibitor AP23464 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

Other records of 2BDJ

  • 2BDJ · MolNFT v2 / PDB Bank · Src kinase in complex with inhibitor AP23464

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.